DHPA

  • Home
  • About Us
    • Leadership
      • Executive Committee
      • Board Members
    • DHPA Members
    • Contact Us
    • Join Us
  • Advocacy
    • Patient Access to Independent GI Care
      • Colorectal Cancer Screening
    • Diversity Equity and Inclusion
    • Modernizing the Stark Law
    • Saving the IOASE
    • Pathology Services Utilization
  • Resources
    • Independent GI Careers
    • Research
    • Fact Sheets
    • Letters to Policymakers
    • Leadership Webinar Series
  • Newsroom
    • Press Releases
    • DHPA in the News
    • GI News Round Up
  • Take Action

July 5, 2016

DHPA Members Voice Opposition to Medicare Part B Proposed Rule

Over the past three months, the Digestive Health Physicians Association (DHPA) has continued to fight for the ability of independent gastroenterology practices to provide high quality and cost-efficient care in the independent GI medical practice setting. In April, we voiced our opposition to the Centers for Medicare and Medicaid (CMS) Proposed Part B Drug Payment Model which, if finalized, would dramatically change Medicare reimbursement for drugs administered in physician offices, including Remicade, which is critical to our treatment of patients with Crohn’s disease and ulcerative colitis.

DHPA joined a coalition of more than 300 leading patient, disease and provider organizations in sending a letter to congressional leadership requesting that they ask the Centers for Medicare & Medicaid Services (CMS) to permanently withdraw its proposed rule to implement a new “Medicare Part B Payment Model.”

DHPA members also contacted their Representatives and Senators urging them to voice opposition to the rule with CMS. At the conclusion of the effort, almost 200 Members of Congress had received more than 1,900 emails urging them to ask CMS to withdraw the proposed rule. Congress heard us loud and clear. Thanks in part to the outpouring of support from the independent GI community, more than 240 Members of Congress signed a bipartisan letter to CMS opposing the proposed rule.

The letter states, “Under CMS’s Medicare drug experiment, numerous physicians would face acquisition costs that exceed the Medicare payment amount for certain drugs. This policy will make it harder for patients to receive the drugs they need and especially hurt seniors who depend on doctors in smaller practices or those who live in rural areas.”

Both Republican and Democratic members of the U.S. Senate Finance Committee have also sent letters expressing concerns with the proposed rule. Several additional letters have also been signed onto by more than 100 House and Senate members.

Additionally, DHPA submitted our own formal comments to CMS urging a withdrawal of the proposed rule.

 

 

Filed Under: Advocacy, Letters to Policymakers, Resources

Member Spotlight

Adult Gastroenterology Associates is a single-specialty GI and hepatology practice serving Tulsa and much of Northeastern Oklahoma, with physicians who specialize in colon cancer screening, treatment of GERD, IBD, and treatment of diseases of the liver and pancreas.

Learn more at:
www.tulsagastro.com

Become a Member

    Is your practice interested in promoting and preserving accessible, high quality and cost-efficient care in the independent GI medical setting? Contact us today about joining DHPA.

    Recent News

    • DHPA Recommends MACRA Improvements to Bipartisan Group of U.S. Representatives

    • New Study in Gastro Journal: GI Patients Consider Telehealth to be the Same as In-Person Visits

    • DHPA Comment Letter on OPPS/ASC Proposed Rule for Calendar Year 2023

    • DHPA Comment Letter on MPFS Proposed Rule for Calendar Year 2023

    • Webinar: Supporting Career Development for Women in GI

    • Reducing the Burden of Colorectal Cancer: AGA Position Statements

    • Dr. Latha Alaparthi Named President & Board Chair of DHPA

    • Independent Healthcare Grants and Charitable Donations (Abbvie)

    • Community Grant Program (Walmart Foundation)

    Digestive Health Physicians Association, Inc.
    10770 Columbia Pike, Suite 400
    Silver Spring, Maryland, 20901
    © 2020 DHPA

    Follow @DHPAnews
    Tweets by DHPAnews

    Copyright © 2023 · Executive Pro Theme on Genesis Framework · WordPress · Log in